Halozyme Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $2.7M | 42k | 63.81 |
| 2024-12-31 | $2.0M | 41k | 47.81 |
| 2024-06-30 | $1.9M | 37k | 52.36 |
| 2023-12-31 | $5.9M | 159k | 36.96 |
| 2023-09-30 | $6.6M | 173k | 38.20 |
| 2023-06-30 | $4.0M | 111k | 36.07 |
| 2023-03-31 | $5.1M | 133k | 38.19 |
| 2022-12-31 | $6.0M | 106k | 56.90 |
| 2022-06-30 | $1.7M | 38k | 44.01 |
| 2020-12-31 | $228k | 5.3k | 42.76 |
| 2017-06-30 | $149k | 12k | 12.82 |
| 2014-03-31 | $282k | 20k | 14.02 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management